Dr. Gignac’s research on suture development, using birds as a model system, has been awarded the January 2024 cover of The Anatomical Record.

Dr. Shanna Hamilton, Assistant Professor of Cellular and Molecular Medicine, received an Investigator Award from Sarver Heart Center. This award will help support Dr. Hamilton's research which involves testing the therapeutic potential of a novel protein to mitigate the effects of calcium-dependent arrhythmias in cardiovascular disease.

Dr. Paul Gignac, Associate Professor of Cellular and Molecular Medicine, and his NSF-funded Non-Clinical Tomography Users Research Network (NoCTURN) were featured in a Nature Magazine article on making research data more open and accessible. Click to read more.

PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer

The Rogers Lab publishes study in Current Biology by lead author John Ryniawec, postdoc, who discovered new regulators of centriole growth, a crucial step during the assembly of this essential and ubiquitous organelle. The authors find that coordination between these evolutionarily conserved regulators is required for reproduction in a fruit fly model organism.

Drs. Valerie Schaibley, Jean Wilson, and Yana Zavros were selected as part of the inaugural Women in Medicine and Science (WIMS) Torchbearer awardees. These awards serve to recognize remarkable achievements and invaluable contributions made by women physicians and scientists.

Anne Cress, PhD, Professor of Cellular and Molecular Medicine and Vice Dean for COM-T Operations and Strategy and Chief of Staff, was selected as a 2023 Woman of Impact. Each year, the Office of Research, Innovation & Impact (RII) selects 30 UArizona faculty and staff members who have made a significant contribution to the UArizona's identity as a world-class research institution.

Dr. Joann Sweasy, Professor of Cellular and Molecular Medicine and Director of the University of Arizona Cancer Center, was recently elected to serve as Vice President/President-Elect of the Association of American Cancer Institutes (AACI) Board of Directors.

Coen Ottenheijm, Associate Professor of Cellular and Molecular Medicine, was awarded a 2.3M grant from the National Institutes of Health. The grant funds will be used to study the role of titin in the pathophysiology of diaphragm weakness during mechanical ventilation. Congratulations, Dr. Ottenheijm!

Read about how CMM researchers are using organoids (tissue or small tumors grown in the lab) to understand and treat cancer and other diseases.